Medical Science Liaison, Oncology in Clinical Research
Pubblicato il 13-08-2026 - Iqvia in La Spezia
IQVIA is seeking a scientifically credible and field-based Medical Science Liaison. You’ll be the key scientific point of contact for clinical trial sites—supporting site engagement, education, and patient recruitment across a diverse and impactful region.
Possiede le competenze per ricoprire questo ruolo? Legga i dettagli completi qui sotto e invii la sua candidatura oggi stesso.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help
improve patient outcomes and population health worldwide.
Location: Field-based – Italy
Territory: Mainly Italy, Greece (when needed Turkey and Israel) with remote options
Key Responsibilities:
- Provide field-based medical support to clinical research programs in oncology.
- Deliver credible, balanced presentations on disease area and investigational therapies to investigators and site staff.
- Engage with clinical trial sites to understand and help resolve medical barriers to patient recruitment and screening.
- Collaborate with site management and monitoring teams to support site initiation and engagement.
- Facilitate compliant scientific exchange with healthcare professionals (HCPs) and key opinion leaders (KOLs).
- Capture and report field intelligence, including protocol feedback, treatment landscape insights, and competitor activity.
- Represent the program at scientific meetings, advisory boards, and congresses.
- Maintain up-to-date knowledge of the disease area, investigational assets, and relevant clinical data.
- Ensure all activities are conducted in accordance with applicable laws, regulations, and company policies.
Required Qualifications:
- Minimum 2 years’ experience as an MSL or in a scientific/medical role.
- Oncology experience is preferred, ideally in solid tumors.
- Fluent in It